Provided criteria for testing are fulfilled (for example, a patient presenting with medullary thyroid cancer (MTC)), insurers will often cover the cost of both germline and somatic RET testing in the USA and Europe. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.